Accès ouvert
2025
article
OpenAlex
Diana Boraschi, Lázaro Moreira Marques Neto, Ling Chen, Luciana C. C. Leite et autres
These authors contributed equally 14 The Vaccine Immunology Network is a spontaneous network born in March 2024, aiming to strengthen the factual collaboration between academic research and industry in the vaccine field, which now includes over 100 participants from 9 countries.
br, cn, hk, se, it
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Shruti Sridhar, Will Harris, Chartsiam Tipgomut, Qiang Pan-Hammarstrom et autres
Abstract Introduction Double Expressor Lymphoma (DEL) refers to diffuse large B-cell lymphoma (DLBCL) with overexpression of the oncogenes MYC and BCL2 and carries a poor prognosis. However, the clinical utility of DEL is limited by variability in definitions for thresholds of positivity …
sg, us, se, cz, fr, de
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Hong Liang, Min Liu, Shruti Sridhar, Charmaine Ong et autres
Abstract Introduction Primary central nervous system lymphoma (PCNSL) is an aggressive B-cell lymphoma exhibiting unique central nervous system (CNS) tropism, and high recurrence rates despite sharing morphological and molecular features with systemic Diffuse Large B-Cell Lymphoma (DLBCL). Given the unique immune landscape …
sg, cn, au, us, se, it
(code pays fourni par la source)
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
Supplemental methods Supplemental Figures Supplemental Figure S1. Overview of somatic copy number alterations in rrDLBCLs. Supplemental Figure S2. Consistent low coverage in the first exon of FOXO1. Supplemental Figure S3. Overview of FOXO1 mutations in rrDLBCLs. Supplemental Figure S4. VAFs corrected using …
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
Targeted capture sequencing
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
targeted sequencing results of rrDLBCL
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
exome sequencing results of rrDLBCL
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
Targeted sequencing of untreated DLBCL and TLy
Accès ouvert
2023
other
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
Abstract Purpose: Relapsed or refractory diffuse large B-cell lymphoma (rrDLBCL) is fatal in 90% of patients, and yet little is known about its biology. Experimental Design: Using exome sequencing, we characterized the mutation profiles of 38 rrDLBCL biopsies obtained at the time …
Accès ouvert
2023
other
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
Abstract Purpose: Relapsed or refractory diffuse large B-cell lymphoma (rrDLBCL) is fatal in 90% of patients, and yet little is known about its biology. Experimental Design: Using exome sequencing, we characterized the mutation profiles of 38 rrDLBCL biopsies obtained at the time …
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
exome sequencing results of rrDLBCL
Accès ouvert
2023
supplementary-materials
OpenAlex
Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri et autres
targeted sequencing results of rrDLBCL